TP53 in MDS and AML: Biological and clinical advances-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TP53 in MDS and AML: Biological and clinical advances

Published:2024-04 Issue: Volume:588 Page:216767
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhao Yeqian,Chen Weihao,Yu Jing,Pei Shanshan,Zhang Qiang,Shi Jimin,Huang He,Zhao Yanmin

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Elsevier BV

Reference89 articles.

1. Cancer incidence, patterns, and genotype–phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study;de Andrade;Lancet Oncol.,2021

2. The 5th edition of the World Health organization classification of haematolymphoid Tumours: myeloid and histiocytic/dendritic neoplasms;Khoury;Leukemia,2022

3. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data;Arber;Blood,2022

4. Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine;Bories;PLoS One,2020

5. TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes;Welch;N. Engl. J. Med.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variation characteristics and clinical significance of TP53 in patients with myeloid neoplasms;Hematology;2024-08-14

2. Shaping the AML Treatment Landscape—Modeling a Path through Plenty, Uncertainty, and Paucity;Journal of Health and Allied Sciences NU;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP